REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 4.88 billion by 2030 | 12.66% | North America |
Market by Product Type | Market by Application | Market by End User |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Global Human Liver Models Market Overview
The global Human Liver Models Market is expected to grow at more than 12.66% CAGR from 2023 to 2030. It is expected to reach above USD 4.88 billion by 2030 from a little above USD 2.12 billion in 2023. Â
There is an increasing demand for alternative testing methods to reduce the reliance on animal models and improve the accuracy of drug toxicity testing. Human liver models provide a more human-relevant and predictive platform for studying liver function, drug metabolism, and toxicity. The pharmaceutical industry is constantly seeking ways to streamline the drug development and discovery process. Human liver models offer a valuable tool for studying drug metabolism, evaluating drug efficacy, and assessing potential adverse effects in a controlled laboratory environment. The field of tissue engineering and 3D cell culture has made significant advancements in recent years. These technologies have enabled the development of more sophisticated and functional human liver models, including organoids, spheroids, and bio-printed constructs, which closely mimic the structure and function of the human liver. Liver diseases, such as hepatitis, non-alcoholic fatty liver disease (NAFLD), and liver cancer, are on the rise globally. Human liver models provide a valuable tool for studying the underlying mechanisms of these diseases, developing new therapeutic strategies, and evaluating drug candidates for liver-related disorders. Personalized medicine aims to tailor medical treatments to an individual’s specific genetic makeup, lifestyle, and disease characteristics. Human liver models can be derived from patient-specific induced pluripotent stem cells (iPSCs), allowing researchers to study liver diseases and test drugs on a personalized basis.
Developing and maintaining human liver models can be costly. The expenses associated with advanced tissue engineering techniques, specialized culture media, equipment, and skilled personnel can limit the adoption of these models, particularly for small-scale research organizations and resource-constrained settings. Despite significant advancements, there are still technical challenges and limitations associated with human liver models. Replicating the complex structure and function of the human liver in an in vitro model remains a challenge. Obtaining a sufficient number of functional hepatocytes, achieving long-term viability, and accurately recapitulating the dynamic interactions between liver cells and other cell types pose technical hurdles.
Human liver models offer an opportunity to enhance the drug discovery and development process. By providing a more human-relevant platform for studying drug metabolism, efficacy, and toxicity, these models can help identify potential drug candidates, predict adverse effects, and improve the success rate of clinical trials. The use of human liver models in early-stage drug screening and personalized medicine can significantly reduce costs and time associated with traditional drug development approaches. Human liver models can be integrated with other organ-on-a-chip technologies, such as lung, kidney, and heart models, to create more comprehensive and physiologically relevant systems. These multi-organ models allow for the study of organ interactions, systemic drug effects, and disease mechanisms, providing a closer representation of human physiology. The integration of human liver models with other organ models presents opportunities for applications in toxicity testing, disease modeling, and personalized medicine.
The pandemic has disrupted research activities in many sectors, including the field of human liver models. Laboratories and research facilities faced closures or limitations due to lockdown measures, social distancing protocols, and reduced access to resources. This has affected the pace of research and development efforts related to human liver models. The urgency to develop treatments and vaccines for COVID-19 has increased the focus on drug development and safety testing. Human liver models have played a crucial role in studying the effects of potential therapeutics and assessing drug-induced liver injury associated with COVID-19 treatments. This has created opportunities for the application of human liver models in COVID-19 research. The COVID-19 pandemic has led to increased funding and investment in life sciences and biotechnology research.
ATTRIBUTE | DETAILS |
Study period | 2020-2030 |
Base year | 2022 |
Estimated year | 2023 |
Forecasted year | 2023-2030 |
Historical period | 2019-2021 |
Unit | Value (USD Billion), (Thousand Units) |
Segmentation | By Product Type, By Application, By End User, By Region |
By Product Type
 |
|
By Application
 |
|
By End User
 |
|
By Region
 |
|
Global Human Liver Models Market Segment Analysis
Based on the product type, market is segmented into liver organoids, liver-on-a-chip, 2D models, animal models and 3D bioprinting. Over the course of the forecast period, the segment with the strongest revenue growth is anticipated to be liver-on-a-chip. Liver-on-a-chip is a straightforward, affordable substitute for animal models that can sustain metabolic activities that are similar to those found in the in vivo environment. However, due to its high potential for producing organs quickly compared to traditional tissue culture procedures, the 3D bioprinting market is anticipated to grow at the quickest rate over the projection period.
Based on the application, market is segmented into educational and drug discovery. Over the projected period, the segment responsible for drug discovery is anticipated to provide a major share of the market’s revenue. The demand for innovative medications to treat uncommon diseases and rising R&D spending are driving segment revenue growth. The increased use of human liver models in drug testing and screening applications as well as the growing demand for improved medications to address the rising incidence of uncommon liver illnesses and cancer are credited with the high revenue growth.
By end user, market is segmented into research institute, biotechnology and pharmaceutical companies. The greatest share was held by the pharmaceutical and biotechnology firms category in 2021, and it is anticipated that this segment would maintain its dominance throughout the projected period. Major firms are concentrating on producing new and more effective pharmaceuticals as a result of the rising occurrence of various ailments, which is assisting market revenue growth. Additionally, this market’s revenue growth is anticipated to be boosted by the growing use of personalized medication therapies to improve patient care.
Global Human Liver Models Market Players
Key competitors from both domestic and international markets compete fiercely in the worldwide global human liver models industry include Organovo Holding Inc., BioIVT, InSphero, Emulate Inc., Mimetas, CN Bio, Cyfuse Biomedical K.K., HuREL Corporation, BICO.
Recent News:
9th May 2022: Emulate upgraded intestinal organ-on-a-chip for exploring inflammatory bowel disease. Organ-on-a-chip maker Emulate had launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that help illustrate how immune cells are activated and circulate through the body.
6th May 2022: BICO acquired Allegro 3D, adding new light-based 3D Bioprinting technology – complementing the existing offering of application tailored products.
Who Should Buy? Or Key stakeholders
- Human Liver Models Manufacturers
- Material Providers
- Distributors
- Pharmaceutical Industry
- Regulatory Bodies
- Research and Development Organization
- Government
- Others
Global Human Liver Models Market Regional Analysis
The global human liver models market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Geographically, the global market for human liver models was led by the North American market in 2021, which also had the greatest revenue share. The forecast term is expected to see North America continuing to contribute the most to revenue. The high prevalence of hepatitis and the rising incidence of non-alcoholic fatty liver disease (NAFLD), as well as the development of the life science sector, are all factors that contribute to the robust revenue share. Additionally, rising government backing, the existence of specialists with the necessary training, rising investments, and a focus on tissue culture diagnostics are some important drivers driving the market’s revenue growth in this area.
During the forecast period, the Asia Pacific region is anticipated to have the quickest revenue CAGR. Some of the major factors propelling growth of the Asia Pacific human liver models market include rising investments in clinical diagnostics, rising awareness of human organoids, rising healthcare costs, rising incidence of liver diseases, and cumulative efforts to improve healthcare infrastructure.
Key Market Segments: Global Human Liver Models Market
Global Human Liver Models Market by Product Type, 2020-2030, (USD Billion), (Thousand Units)
- Liver Organoids
- Liver-on-a-chip
- 2D Models
- Animals Models
- 3D Bioprinting
Global Human Liver Models Market by Application, 2020-2030, (USD Billion), (Thousand Units)
- Educational
- Drug Discovery
Global Human Liver Models Market by End User, 2020-2030, (USD Billion), (Thousand Units)
- Research Institute
- Biotechnology
- Pharmaceutical Companies
Global Human Liver Models Market by Region, 2020-2030, (USD Billion), (Thousand Units)
- North America
- Europe
- Asia Pacific
- South America
- Middle East and Africa
IMPORTANT COUNTRIES IN ALL REGIONS ARE COVERED
Key Question Answered
- What is the expected growth rate of the human liver models market over the next 7 years?
- Who are the major players in the human liver models market and what is their market share?
- What are the end-user industries driving demand for market and what is their outlook?
- What are the opportunities for growth in emerging markets such as Asia-Pacific, Middle East, and Africa?
- How is the economic environment affecting the human liver models market, including factors such as interest rates, inflation, and exchange rates?
- What is the expected impact of government policies and regulations on the human liver models market?
- What is the current and forecasted size and growth rate of the global human liver models market?
- What are the key drivers of growth in the human liver models market?
- What are the distribution channels and supply chain dynamics in the human liver models market?
- What are the technological advancements and innovations in the human liver models market and their impact on product development and growth?
- What are the regulatory considerations and their impact on the market?
- What are the challenges faced by players in the human liver models market and how are they addressing these challenges?
- What are the opportunities for growth and expansion in the human liver models market?
- What are the product offerings and specifications of leading players in the market?
- What is the pricing trend of human liver models in the market and what is the impact of raw material prices on the price trend?
Exactitude Consultancy Services Key Objectives
- Increasing sales and market share
- Developing new technology
- Improving profitability
- Entering new market
- Enhancing brand reputation
Table of Content
- INTRODUCTION
- MARKET DEFINITION
- MARKET SEGMENTATION
- RESEARCH TIMELINES
- ASSUMPTIONS AND LIMITATIONS
- RESEARCH METHODOLOGY
- DATA MINING
- SECONDARY RESEARCH
- PRIMARY RESEARCH
- SUBJECT-MATTER EXPERTS’ ADVICE
- QUALITY CHECKS
- FINAL REVIEW
- DATA TRIANGULATION
- BOTTOM-UP APPROACH
- TOP-DOWN APPROACH
- RESEARCH FLOW
- DATA SOURCES
- DATA MINING
- EXECUTIVE SUMMARY
- MARKET OVERVIEW
- GLOBAL HUMAN LIVER MODELS MARKET OUTLOOK
- MARKET DRIVERS
- MARKET RESTRAINTS
- MARKET OPPORTUNITIES
- IMPACT OF COVID-19 ON HUMAN LIVER MODELS MARKET
- PORTER’S FIVE FORCES MODEL
- THREAT FROM NEW ENTRANTS
- THREAT FROM SUBSTITUTES
- BARGAINING POWER OF SUPPLIERS
- BARGAINING POWER OF CUSTOMERS
- DEGREE OF COMPETITION
- INDUSTRY VALUE CHAIN ANALYSIS
- GLOBAL HUMAN LIVER MODELS MARKET OUTLOOK
- GLOBAL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE, 2020-2030, (USD BILLION), (THOUSAND UNITS)
- LIVER ORGANOIDS
- LIVER-ON-A-CHIP
- 2D MODELS
- ANIMALS MODELS
- 3D BIOPRINTING
- GLOBAL HUMAN LIVER MODELS MARKET BY APPLICATION, 2020-2030, (USD BILLION), (THOUSAND UNITS)
- EDUCATIONAL
- DRUG DISCOVERY
- GLOBAL HUMAN LIVER MODELS MARKET BY END USER, 2020-2030, (USD BILLION), (THOUSAND UNITS)
- RESEARCH INSTITUTE
- BIOTECHNOLOGY
- PHARMACEUTICAL COMPANIES
- GLOBAL HUMAN LIVER MODELS MARKET BY REGION, 2020-2030, (USD BILLION), (THOUSAND UNITS)
- NORTH AMERICA
- US
- CANADA
- MEXICO
- SOUTH AMERICA
- BRAZIL
- ARGENTINA
- COLOMBIA
- REST OF SOUTH AMERICA
- EUROPE
- GERMANY
- UK
- FRANCE
- ITALY
- SPAIN
- RUSSIA
- REST OF EUROPE
- ASIA PACIFIC
- INDIA
- CHINA
- JAPAN
- SOUTH KOREA
- AUSTRALIA
- SOUTH-EAST ASIA
- REST OF ASIA PACIFIC
- MIDDLE EAST AND AFRICA
- UAE
- SAUDI ARABIA
- SOUTH AFRICA
- REST OF MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPANY PROFILES*(BUSINESS OVERVIEW, COMPANY SNAPSHOT, PRODUCTS OFFERED, RECENT DEVELOPMENTS)
- ORGANOVO HOLDINGS INC.
- BIOIVT
- INSPHERO
- EMULATE, INC.
- MIMETAS
- CN BIO
- CYFUSE BIOMEDICAL K.K.
- HUREL CORPORATION
- BICO*THE COMPANY LIST IS INDICATIVE
LIST OF TABLES
TABLE 1 GLOBAL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 2 GLOBAL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 3 GLOBAL HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 4 GLOBAL HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 5 GLOBAL HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 6 GLOBAL HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 7 GLOBAL HUMAN LIVER MODELS MARKET BY REGION (USD BILLION) 2020-2030
TABLE 8 GLOBAL HUMAN LIVER MODELS MARKET BY REGION (THOUSAND UNITS) 2020-2030
TABLE 9 NORTH AMERICA HUMAN LIVER MODELS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 10 NORTH AMERICA HUMAN LIVER MODELS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 11 NORTH AMERICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 12 NORTH AMERICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 13 NORTH AMERICA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 14 NORTH AMERICA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 15 NORTH AMERICA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 16 NORTH AMERICA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 17 US HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 18 US HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 19 US HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 20 US HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 21 US HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 22 US HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 23 CANADA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 24 CANADA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 25 CANADA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 26 CANADA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 27 CANADA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 28 CANADA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 29 MEXICO HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 30 MEXICO HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 31 MEXICO HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 32 MEXICO HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 33 MEXICO HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 34 MEXICO HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 35 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 36 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 37 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 38 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 39 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 40 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 41 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 42 SOUTH AMERICA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 43 BRAZIL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 44 BRAZIL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 45 BRAZIL HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 46 BRAZIL HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 47 BRAZIL HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 48 BRAZIL HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 49 ARGENTINA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 50 ARGENTINA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 51 ARGENTINA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 52 ARGENTINA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 53 ARGENTINA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 54 ARGENTINA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 55 COLOMBIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 56 COLOMBIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 57 COLOMBIA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 58 COLOMBIA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 59 COLOMBIA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 60 COLOMBIA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 61 REST OF SOUTH AMERICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 62 REST OF SOUTH AMERICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 63 REST OF SOUTH AMERICA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 64 REST OF SOUTH AMERICA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 65 REST OF SOUTH AMERICA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 66 REST OF SOUTH AMERICA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 67 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 68 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 69 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 70 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 71 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 72 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 73 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 74 ASIA-PACIFIC HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 75 INDIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 76 INDIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 77 INDIA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 78 INDIA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 79 INDIA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 80 INDIA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 81 CHINA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 82 CHINA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 83 CHINA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 84 CHINA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 85 CHINA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 86 CHINA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 87 JAPAN HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 88 JAPAN HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 89 JAPAN HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 90 JAPAN HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 91 JAPAN HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 92 JAPAN HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 93 SOUTH KOREA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 94 SOUTH KOREA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 95 SOUTH KOREA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 96 SOUTH KOREA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 97 SOUTH KOREA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 98 SOUTH KOREA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 99 AUSTRALIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 100 AUSTRALIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 101 AUSTRALIA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 102 AUSTRALIA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 103 AUSTRALIA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 104 AUSTRALIA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 105 SOUTH-EAST ASIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 106 SOUTH-EAST ASIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 107 SOUTH-EAST ASIA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 108 SOUTH-EAST ASIA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 109 SOUTH-EAST ASIA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 110 SOUTH-EAST ASIA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 111 REST OF ASIA PACIFIC HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 112 REST OF ASIA PACIFIC HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 113 REST OF ASIA PACIFIC HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 114 REST OF ASIA PACIFIC HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 115 REST OF ASIA PACIFIC HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 116 REST OF ASIA PACIFIC HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 117 EUROPE HUMAN LIVER MODELS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 118 EUROPE HUMAN LIVER MODELS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 119 EUROPE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 120 EUROPE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 121 EUROPE HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 122 EUROPE HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 123 EUROPE HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 124 EUROPE HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 125 GERMANY HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 126 GERMANY HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 127 GERMANY HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 128 GERMANY HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 129 GERMANY HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 130 GERMANY HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 131 UK HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 132 UK HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 133 UK HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 134 UK HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 135 UK HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 136 UK HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 137 FRANCE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 138 FRANCE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 139 FRANCE HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 140 FRANCE HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 141 FRANCE HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 142 FRANCE HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 143 ITALY HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 144 ITALY HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 145 ITALY HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 146 ITALY HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 147 ITALY HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 148 ITALY HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 149 SPAIN HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 150 SPAIN HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 151 SPAIN HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 152 SPAIN HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 153 SPAIN HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 154 SPAIN HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 155 RUSSIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 156 RUSSIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 157 RUSSIA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 158 RUSSIA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 159 RUSSIA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 160 RUSSIA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 161 REST OF EUROPE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 162 REST OF EUROPE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 163 REST OF EUROPE HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 164 REST OF EUROPE HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 165 REST OF EUROPE HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 166 REST OF EUROPE HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 167 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY COUNTRY (USD BILLION) 2020-2030
TABLE 168 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY COUNTRY (THOUSAND UNITS) 2020-2030
TABLE 169 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 170 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 171 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 172 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 173 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 174 MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 175 UAE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 176 UAE HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 177 UAE HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 178 UAE HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 179 UAE HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 180 UAE HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 181 SAUDI ARABIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 182 SAUDI ARABIA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 183 SAUDI ARABIA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 184 SAUDI ARABIA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 185 SAUDI ARABIA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 186 SAUDI ARABIA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 187 SOUTH AFRICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 188 SOUTH AFRICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 189 SOUTH AFRICA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 190 SOUTH AFRICA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 191 SOUTH AFRICA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 192 SOUTH AFRICA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
TABLE 193 REST OF MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (USD BILLION) 2020-2030
TABLE 194 REST OF MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY PRODUCT TYPE (THOUSAND UNITS) 2020-2030
TABLE 195 REST OF MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY APPLICATION (USD BILLION) 2020-2030
TABLE 196 REST OF MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY APPLICATION (THOUSAND UNITS) 2020-2030
TABLE 197 REST OF MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY END USER (USD BILLION) 2020-2030
TABLE 198 REST OF MIDDLE EAST AND AFRICA HUMAN LIVER MODELS MARKET BY END USER (THOUSAND UNITS) 2020-2030
LIST OF FIGURES
FIGURE 1 MARKET DYNAMICS
FIGURE 2 MARKET SEGMENTATION
FIGURE 3 REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4 DATA TRIANGULATION
FIGURE 5 BOTTOM-UP APPROACH
FIGURE 6 TOP-DOWN APPROACH
FIGURE 7 RESEARCH FLOW
FIGURE 8 GLOBAL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE, USD BILLION, 2020-2030
FIGURE 9 GLOBAL HUMAN LIVER MODELS MARKET BY APPLICATION, USD BILLION, 2020-2030
FIGURE 10 GLOBAL HUMAN LIVER MODELS MARKET BY END USER, USD BILLION, 2020-2030
FIGURE 11 GLOBAL HUMAN LIVER MODELS MARKET BY REGION, USD BILLION, 2020-2030
FIGURE 12 PORTER’S FIVE FORCES MODEL
FIGURE 13 GLOBAL HUMAN LIVER MODELS MARKET BY PRODUCT TYPE, USD BILLION, 2022
FIGURE 14 GLOBAL HUMAN LIVER MODELS MARKET BY APPLICATION, USD BILLION, 2022
FIGURE 15 GLOBAL HUMAN LIVER MODELS MARKET BY END USER, USD BILLION, 2022
FIGURE 16 GLOBAL HUMAN LIVER MODELS MARKET BY REGION, USD BILLION, 2022
FIGURE 17 NORTH AMERICA HUMAN LIVER MODELS MARKET SNAPSHOT
FIGURE 18 EUROPE HUMAN LIVER MODELS MARKET SNAPSHOT
FIGURE 19 SOUTH AMERICA HUMAN LIVER MODELS MARKET SNAPSHOT
FIGURE 20 ASIA PACIFIC HUMAN LIVER MODELS MARKET SNAPSHOT
FIGURE 21 MIDDLE EAST ASIA AND AFRICA HUMAN LIVER MODELS MARKET SNAPSHOT
FIGURE 22 MARKET SHARE ANALYSIS
FIGURE 23 ORGANOVO HOLDINGS INC.: COMPANY SNAPSHOT
FIGURE 24 BIOIVT: COMPANY SNAPSHOT
FIGURE 25 INSPHERO: COMPANY SNAPSHOT
FIGURE 26 EMULATE, INC.: COMPANY SNAPSHOT S
FIGURE 27 MIMETAS: COMPANY SNAPSHOT
FIGURE 28 CN BIO: COMPANY SNAPSHOT
FIGURE 29 CYFUSE BIOMEDICAL K.K.: COMPANY SNAPSHOT
FIGURE 30 HUREL CORPORATION: COMPANY SNAPSHOT
FIGURE 31 BICO: COMPANY SNAPSHOT
FAQ
Some key players operating in the global human liver models market include Organovo Holding Inc., BioIVT, InSphero, Emulate Inc., Mimetas, CN Bio, Cyfuse Biomedical K.K., HuREL Corporation, BICO.
There is an increasing demand for alternative testing methods to reduce the reliance on animal models and improve the accuracy of drug toxicity testing. Human liver models provide a more human-relevant and predictive platform for studying liver function, drug metabolism, and toxicity.
The global human liver models market size is expected to grow at more than 12.66% CAGR from 2023 to 2030. It is expected to reach above USD 4.88 billion by 2030 from a little above USD 2.12 billion in 2023.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.